TECHNIKER KRANKENKASSE
A United Kingdom buyer, with 20 published contracts, worth £3, most recently 4 months ago.
Top 5 suppliers won 300% of awarded value — £6 of £2 across 10 awards.
This contract opportunity is for pharmaceutical companies to enter into discount agreements for the drug Epoetin beta, as part of the Open-House-Biologika process. The participating health insurance funds aim to establish uniform discount contracts without individual negotiations, ensuring no exclus
The health insurance funds (whether HEK and/or hkk participate in each lot is determined by the designation of the respective lot) aim to enter into discount contracts with all suitable pharmaceutical companies according to § 130a Abs. 8 SGB V for the active ingredients, combinations of active ingre
The health insurance funds (whether HEK and/or hkk participate in each lot is determined by the designation of the respective lot) aim to establish discount contracts with all suitable pharmaceutical companies according to § 130a Abs. 8 SGB V for the active ingredients, combinations of active ingred
The Techniker Krankenkasse (TK) aims to establish discount contracts with all suitable pharmaceutical companies for the combination of active ingredients Formoterol/Glycopyrronium/Budesonide, in accordance with § 130a Abs. 8 SGB V. The contract will be concluded under TK's Open House Original proced
The Techniker Krankenkasse (TK) aims to establish discount contracts with all suitable pharmaceutical companies for the active ingredient Abemaciclib, in accordance with § 130c Abs. 1 SGB V. This contract will be part of TK's Open House Original procedure, where individual negotiations on contract t
The health insurance funds (whether HEK and/or hkk participate in each lot is determined by the designation of the respective lot) aim to establish discount contracts with all suitable pharmaceutical companies according to § 130a Abs. 8 SGB V for the active ingredients, combinations of active ingred
The health insurance companies TK and HEK aim to establish contracts with all suitable companies for the supply of disposable batteries for cochlear implant speech processors under uniform conditions. Individual negotiations on contract terms will not be conducted; uniform conditions apply. The heal
The Techniker Krankenkasse (TK) aims to establish discount contracts with all suitable pharmaceutical companies for the combination of active ingredients Beclometasone, Formoterol, and Glycopyrronium (ATC: R03AL09) under Section 130a (8) of the Social Code Book V. The contract will be concluded as p
The health insurance funds (whether HEK and/or hkk participate in the respective lot is determined by the designation of the respective lot) aim to enter into discount contracts with all suitable pharmaceutical companies according to § 130a Abs. 8 SGB V for the active ingredients, combinations of ac
